Stem cells have attracted much attention due to their roles in immune regulation, inflammation control, and regeneration. As a very promising therapeutics, a number of companies and research institutes are in the process of commercializing stem cell therapy. However, several challenges remain for stem cell therapy resulting from their weak expression of target genes and a highly variable therapeutic efficacy due to variability among donors and tissue sources. Continued exploration that address these challenges is needed to improve therapeutic efficacy.

 

To standardizing therapeutic potency of the stem cell therapy, we developed IntenCell® through the "S-I-S culture platform" that can minimize the genetic heterogeneity of stem cells and increase effective gene expression through cytokine stimulation.